Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +500 | +2.9% | $0.00 | 17.7K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$60.4K | -179 | -1.01% | $337.32 | 17.5K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +347 | +1.98% | $0.00 | 17.9K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$41.8K | -124 | -0.69% | $337.32 | 17.8K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +253 | +1.42% | $0.00 | 18K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$30.7K | -91 | -0.5% | $337.32 | 17.9K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +361 | +2.01% | $0.00 | 18.3K | Sep 2, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$43.5K | -129 | -0.71% | $337.32 | 18.2K | Sep 2, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +495 | +2.73% | $0.00 | 18.7K | Sep 3, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$59.2K | -177 | -0.95% | $334.31 | 18.5K | Sep 3, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -500 | -24.96% | $0.00 | 1.5K | Sep 1, 2024 | Bio-Rad A Common Stock | 500 | $0.00 | Direct | F2, F3 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -347 | -33.33% | $0.00 | 694 | Sep 1, 2024 | Bio-Rad A Common Stock | 347 | $0.00 | Direct | F2, F4 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -253 | -49.9% | $0.00 | 254 | Sep 1, 2024 | Bio-Rad A Common Stock | 253 | $0.00 | Direct | F2, F5 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -361 | -100% | $0.00 | 0 | Sep 2, 2024 | Bio-Rad A Common Stock | 361 | $0.00 | Direct | F2, F6 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -495 | -100% | $0.00 | 0 | Sep 3, 2024 | Bio-Rad A Common Stock | 495 | $0.00 | Direct | F2, F7 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F3 | On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F4 | On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F5 | On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F6 | On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F7 | On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |